44 results on '"Morisset J"'
Search Results
2. Significance of Cysts in the Diagnosis of Fibrotic Interstitial Lung Disease
3. POS0123 ASSOCIATION OF LUNG IMAGING PATTERN WITH PROGNOSIS AND IMMUNOSUPPRESSION RESPONSE IN CONNECTIVE TISSUE DISEASE ASSOCIATED INTERSTITIAL LUNG DISEASE
4. POS1242 COMPUTED TOMOGRAPHY FINDINGS IN CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE
5. Clinical and Radiographic Characterization of Non-specific Interstitial Pneumonia on High-resolution CT Chest Imaging
6. Characteristics of Arterial Blood Gas in Patients With Fibrotic Interstitial Lung Disease
7. Increasing Honeycombing and Traction Bronchiectasis on Computed Tomography Are Independent Predictors of Survival Across All Interstitial Lung Disease Subtypes
8. Bronchoalveolar Lavage Fluid and Radiographic Patterns in Patients With Fibrotic Interstitial Lung Disease
9. Organic and Inorganic Exposures Are Associated With Radiologic Features in Patients With Fibrotic Interstitial Lung Disease
10. Computed Tomography Features Influencing Guideline-defined Radiologic Patterns In Interstitial Lung Disease
11. Radiologic Patterns and Leading Clinical Diagnoses in Unclassifiable Interstitial Lung Disease
12. Clinical and Radiographic Predictors of Mortality or Transplant in Patients With Idiopathic Pulmonary Fibrosis
13. The Clinical Frailty Scale Is Associated With Mortality in Patients With Fibrotic Interstitial Lung Disease - A Multicenter Cohort Study
14. Dyspnea During Sexual Activity in Patients With Fibrotic Interstitial Lung Disease
15. Mortality of SARS-CoV-2 Infection in Patients With Fibrotic Interstitial Lung Disease
16. Monocyte Count and Transplant-free Survival in Patients With Fibrotic Interstitial Lung Disease
17. Telomere length measurement in the pre lung transplant evaluation of patients with interstitial lung disease
18. 6-minute walk test in fibrotic interstitial lung disease (ILD)
19. Defining Optimal Settings for Lung Cryobiopsy in Interstital Lung Disease
20. Perceptions of Genetic Testing: A Mixed-Methods Study of Patients with Pulmonary Fibrosis and Their First-Degree Relatives
21. Understanding the Decision-Making Process of the Multidisciplinary Approach for the Diagnosis of Interstitial Lung Disease: A Qualitative Study
22. Inhalational Exposures and Fibrotic Interstitial Lung Disease: Presentation, Prevalence, and Survival in the Canadian Registry for Pulmonary Fibrosis
23. Effect of Smoking Status on Interstitial Lung Disease: Novel Insights from the Prospective Canadian Registry for Pulmonary Fibrosis
24. Prevalence and Characteristics of Progressive Fibrosing Interstitial Lung Disease: Results from the Prospective Canadian Registry for Pulmonary Fibrosis
25. Tolerability of Mycophenolate and Azathioprine in Patients with Fibrotic Interstitial Lung Disease: A Prospective Cohort Study Using Real-World Data
26. Sex Based Differences in the Treatment of Interstitial Lung Diseases in Canada
27. Malignancy Risk Associated with Mycophenolate Mofetil and Azathioprine in Patients with Fibrotic Interstitial Lung Disease
28. 'Real World' Therapeutic Approach and Associations with FVC Decline in IPF Patients Treated with Antifibrotics
29. Association of Body Mass Index and Change in Weight with Mortality in Patients with Fibrotic Interstitial Lung Disease
30. The Impact of Pulmonary Hypertension on Outcomes in Interstitial Lung Disease in a Large Canadian Cohort
31. Change in 6-Minute Walk Distance During in- and Outpatient Pulmonary Rehabilitation Is Associated with Improved Survival in Patients with Fibrotic Interstitial Lung Disease
32. Evaluating the Association of Comorbidity Clusters in Fibrotic Interstitial Lung Disease
33. Interstitial Lung Disease Multidisciplinary Meeting Standardization: First Round of an International Modified Delphi Survey
34. Predicting New-Onset Exertional Hypoxemia in Interstitial Lung Disease
35. Supplemental Oxygen Use in Patients with Fibrotic Interstitial Lung Disease: An International Qualitative Study
36. Differences in the Approach to Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE IPF) Between Expert Centres and General Pulmonologists: Results from an International Survey
37. Minimally Important Difference (MID) for the European Quality of Life - 5 Dimensions (EQ-5D) in Fibrotic Interstitial Lung Disease
38. Causes of Hypersensitivity Pneumonitis: Literature Review and Development of a Knowledge Translation Tool
39. Impact of a Regional Multidisciplinary Conference on the Diagnosis of Interstitial Lung Disease
40. Physiological Response to Exercise and Vital Prognosis in Patients with Combined Pulmonary Fibrosis and Emphysema: Comparison to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
41. Disparities in the Treatment of Patients with Interstitial Lung Disease in Canada
42. Derivation and Validation of a Diagnostic Prediction Model for Interstitial Lung Disease
43. Predictors of Mortality on Cardiopulmonary Exercise Testing in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
44. Ein globaler Blick auf akute Exazerbationen der idiopathischen Lungenfibrose (AE-IPF): Ergebnisse einer internationalen Umfrage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.